Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | GPR52 | Q9Y2T5 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 3/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | CES2 | O00748 | 1/20 | 0.40 |
| ▸ | CES1 | P23141 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | LIMK2 | P53671 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12422802 | 0.93 | CYP2C19 (0.44) | CYP2C19TAS2R14MAPTNPC1RAB9A | |
| SCHEMBL12422791 | 0.87 | G6PC1 (0.43) | ALDH1A1MEN1KMT2ATSHR | |
| SCHEMBL12422843 | 0.83 | MAPT (0.46) | TAS2R14MAPTNPC1RAB9AMEN1 | |
| SCHEMBL12422804 | 0.78 | CYP2C19 (0.43) | CYP2C19TAS2R14NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL12422886 | 0.78 | ACHE (0.54) | TAS2R14NPC1RAB9AALDH1A1MAPK1 | |
| SCHEMBL12422811 | 0.76 | L3MBTL1 (0.46) | TAS2R14ALDH1A1HPGDMEN1KMT2A | |
| SCHEMBL12422807 | 0.76 | ACHE (0.51) | CYP2C19TAS2R14NPC1RAB9AALDH1A1 | |
| SCHEMBL12422840 | 0.75 | KMT2A (0.38) | CYP2C19MAPTALDH1A1MEN1KMT2A | |
| SCHEMBL12422809 | 0.74 | PYCR1 (0.41) | MAPTNPC1RAB9ASMN1; SMN2MEN1 | |
| SCHEMBL1403755 | 0.74 | ALDH1A1 (0.48) | NPC1RAB9AALDH1A1SMN1; SMN2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7977020-B2 | Electrophotographic photoreceptor containing enamine compound, image formation apparatus provided with the same, enamine compound and method for producing the same | SHARP KABUSHIKI KAISHA (JP) | 2011-07-12 | — | — | US | disclosed |
| US-7977020-B2 | Electrophotographic photoreceptor containing enamine compound, image formation apparatus provided with the same, enamine compound and method for producing the same | SHARP KABUSHIKI KAISHA (JP) | 2011-07-12 | — | — | US | disclosed |
| US-20080286671-A1 | Electrophotographic photoreceptor containing enamine compound, image formation apparatus provided with the same, enamine compound and method for producing the same | SHARP KABUSHIKI KAISHA (JP) | 2008-11-20 | — | — | US | disclosed |
| US-20080286671-A1 | Electrophotographic photoreceptor containing enamine compound, image formation apparatus provided with the same, enamine compound and method for producing the same | SHARP KABUSHIKI KAISHA (JP) | 2008-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080286671-A1 | Electrophotographic photoreceptor containing enamine compound, image formation apparatus provided with the same, enamine compound and method for producing the same | SLC1A2, SLC1A1, SLC18A1 | CYP2C19 2058/4885TAS2R14 2159/4885MAPT 1322/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.